S. Neslihan Alpay

Targeted Silencing of Elongation Factor 2 Kinase Suppresses Growth and Sensitizes Tumors to Doxorubicin in an Orthotopic Model of Breast Cancer

İbrahim Tekedereli, S. Neslihan Alpay, Clint D.J. Tavares et al. · PLoS ONE · 2012 · 118 citations · Full text

Life Sciences, Oncology, Pharmacology +17

Therapeutic Silencing of Bcl-2 by Systemically Administered siRNA Nanotherapeutics Inhibits Tumor Growth by Autophagy and Apoptosis and Enhances the Efficacy of Chemotherapy in Orthotopic Xenograft Models of ER (−) and ER (+) Breast Cancer

İbrahim Tekedereli, S. Neslihan Alpay, Uǧur Akar et al. · Molecular Therapy — Nucleic Acids · 2013 · 101 citations · Full text

Medicine, Oncology, Pharmacology +17

Erythropoietin Stimulates Tumor Growth via EphB4

Sunila Pradeep, Jie Huang, Edna Mora et al. · Cancer Cell · 2015 · 98 citations · Full text

Medicine, Cancer Biology, Oncology +10

Elongation factor‐2 kinase regulates <scp>TG</scp>2/β1 integrin/Src/u<scp>PAR</scp> pathway and epithelial–mesenchymal transition mediating pancreatic cancer cells invasion

Ahmed A. Ashour, Nilgün Gürbüz, S. Neslihan Alpay et al. · Journal of Cellular and Molecular Medicine · 2014 · 91 citations · Full text

Medicine, Cell Biology, Oncology +17

Targeting elongation factor-2 kinase (eEF-2K) induces apoptosis in human pancreatic cancer cells

Ahmed A. Ashour, Abdel‐Aziz H. Abdel‐Aziz, Ahmed M. Mansour et al. · APOPTOSIS · 2013 · 88 citations

Life Sciences, Cell Biology, Oncology +16